A Norwegian Trial Comparing Treatment Strategies for Carpal Tunnel Syndrome

PHASE4RecruitingINTERVENTIONAL
Enrollment

258

Participants

Timeline

Start Date

April 8, 2022

Primary Completion Date

March 31, 2027

Study Completion Date

March 31, 2028

Conditions
Carpal Tunnel Syndrome
Interventions
PROCEDURE

Surgical carpal tunnel release

Open surgical division of the flexor retinaculum of the palm/wrist to release pressure on the median nerve

DRUG

Injection, Triamcinolone Hexacetonide, Per 5 Mg

Ultrasound-guided injection of 20 mg of triamcinolone hexacetonide (or -acetonide) into the carpal tunnel space close to the median nerve

Trial Locations (5)

1450

RECRUITING

Department of Surgery and Anesthesiology, Diakonhjemmet Hospital, Oslo

1461

RECRUITING

Akershus University Hospital, Lørenskog

0319

ACTIVE_NOT_RECRUITING

Department of Rheumatology, Diakonhjemmet Hospital, Oslo

Unknown

RECRUITING

Department of Orthopedic Surgery, Martina Hansens Hospital, Sandvika

RECRUITING

Department of Rheumatology, Martina Hansens Hospital, Sandvika

All Listed Sponsors
collaborator

Oslo University Hospital

OTHER

collaborator

Martina Hansen's Hospital

OTHER

collaborator

South-Eastern Norway Regional Health Authority

OTHER

collaborator

University Hospital, Akershus

OTHER

lead

Diakonhjemmet Hospital

OTHER